FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to cyclosporine analogues, which possess antiviral activity with respect to HCV, their pharmaceutical compositions and method of treating viral infection in person.
EFFECT: elaboration of method of treating viral infection in person.
12 cl, 1 tbl, 131 ex
Title |
Year |
Author |
Number |
METHODS FOR OBTAINING BENZODIAZEPINE DERIVATIVES |
2018 |
- Kim, In Dzhong
- Ju, Dzhianming
- Blejsdell, Tomas, P.
- Panarese, Dzhozef
- Shuk, Brajan, S.
- Or, Yaat, San
|
RU2794124C2 |
HEPATITIS C VIRUS INHIBITORS |
2010 |
- Tsju Jao-Lin
- Van Tseh
- Pehn Sjaovehn'
- In Lu
- Or Jat San
|
RU2544010C2 |
THIAZOLIDINONE COMPOUNDS AND USE THEREOF FOR TREATING MENTAL OR NEUROLOGICAL DISORDERS AND INFLAMMATION, PARTICULARLY NEUROINFLAMMATION |
2015 |
- Rajmon Zhan-Lui
- Nikolussi Simon
- Gerch Yurg
|
RU2734253C2 |
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF |
2015 |
- Veng Gotsyan
- Or Yat Sun
- Shen Zhujchao
- Lun Tszyan
- Daj Pen
- Sin Syuechao
- Khe Tszin
|
RU2707280C2 |
COMPOUND AIMED AT PROTEIN AND DEGRADATION THEREOF, AND METHOD FOR PRODUCTION AND USE THEREOF |
2021 |
|
RU2829459C1 |
FIVE-MEMBERED HETEROCYCLES AS INHIBITORS OF LEUKOCYTE ADHESION AND VLA-4 ANTAGONISTS |
1997 |
- Shtil'Ts Khans Ul'Rikh
- Vener Fol'Kmar
- Knolle Jokhen
- Bartnik Ehkart
- Khjul'S Kristof
|
RU2229296C2 |
SUBSTITUTED DERIVATIVES OF IMIDAZOLIDINE, METHOD FOR PREPARING AND PHARMACEUTICAL PREPARATION |
1998 |
- Vener Fol'Kmar
- Shtil'Ts Khans Ul'Rikh
- Shmidt Vol'Fgang
- Zajffge Dirk
|
RU2239641C2 |
PRODUCT COMPRISING AT LEAST ONE SUBSTANCE INHIBITING ACTIVITY OF NO-SYNTHASE IN COMBINATION WITH AT LEAST ONE SUBSTANCE INHIBITING ACTIVITY OF PHOSPHOLIPASE A |
2000 |
- Oge Mishel'
- Shabrie De Lasson'Er P'Er-Eht'Enn
|
RU2256465C2 |
QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS |
2007 |
- Or Jat Sun'
- Mur Dzhoel D.
- Lju Dun
- Sun' In
- Gaj Junkhua
- Tan Datun
- Nju Dehtsjan
- Sjuj Goju
- Van Chzheh
|
RU2475494C2 |
NEW PHOSPHORUS-CONTAINING THYMOMIMETIC DRUGS |
2004 |
- Ehrion Mark D.
- Dzhiang Khongdzhian
- Bojer Serzh Kh.
|
RU2422450C2 |